Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions
Author:
Affiliation:
1. Janssen Research & Development; LLC; Raritan New Jersey
2. Bayer HealthCare Pharmaceuticals; Montville New Jersey
3. Bayer HealthCare Pharmaceuticals; Wuppertal Germany
Publisher
Wiley
Subject
History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/nyas.12136/fullpdf
Reference70 articles.
1. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition);Ansell;Chest,2008
2. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety;Hirsh;Chest,1998
3. The discovery and development of rivaroxaban;Misselwitz;Ann. N.Y. Acad. Sci,2011
4. The discovery and development of rivaroxaban, an oral, direct Factor Xa inhibitor;Perzborn;Nat. Rev. Drug Discov,2011
5. In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939-an oral, direct Factor Xa inhibitor;Perzborn;J. Thromb. Haemost,2005
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective;European Journal of Medicinal Chemistry;2024-09
2. UVPD Spectroscopy of Differential Mobility-Selected Prototropic Isomers of Rivaroxaban;The Journal of Physical Chemistry A;2021-08-25
3. Structural and Binding Effects of Chemical Modifications on Thrombin Binding Aptamer (TBA);Molecules;2021-07-30
4. A simple and sensitive HILIC-based UHPLC-MS/MS method for quantifying of rivaroxaban in dried blood spots: Application in comparison with the plasma sample method;Journal of Pharmaceutical and Biomedical Analysis;2021-05
5. Liquid chromatography–tandem mass spectrometry method for determination of rivaroxaban in human plasma and its application to a pharmacokinetic study;European Journal of Mass Spectrometry;2019-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3